Nikulski Financial, Inc. Abb Vie Inc. Transaction History

Nikulski Financial, Inc.

$333 Million
Q4 2024

A detailed history of Nikulski Financial, Inc. transactions in Abb Vie Inc. stock. As of the latest transaction made, Nikulski Financial, Inc. holds 38,977 shares of ABBV stock, worth $7.88 Million. This represents 2.08% of its overall portfolio holdings.

Number of Shares

38,977

Previous 37,806 3.1%

Holding current value

$7.88 Million

Previous $7.47 Million 7.22%

% of portfolio

2.08%

Previous 2.26%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 21, 2025	BUY	$164.99 - $203.87 $193,203 - $238,731	1,171 Added 3.1%	38,977 $6.93 Million
Q3 2024 Oct 28, 2024	BUY	$163.84 - $199.33 $43,253 - $52,623	264 Added 0.7%	37,806 $7.47 Million
Q2 2024 Jul 30, 2024	SELL	$154.79 - $180.76 $119,033 - $139,004	-769 Reduced 2.01%	37,542 $6.44 Million
Q1 2024 Apr 18, 2024	SELL	$159.82 - $182.1 $61,211 - $69,744	-383 Reduced 0.99%	38,311 $6.98 Million
Q4 2023 Feb 01, 2024	SELL	$137.6 - $154.97 $79,257 - $89,262	-576 Reduced 1.47%	38,694 $6 Million
Q3 2023 Oct 17, 2023	BUY	$133.59 - $154.65 $754,917 - $873,927	5,651 Added 16.81%	39,270 $5.85 Million
Q2 2023 Jul 27, 2023	BUY	$132.51 - $164.9 $142,978 - $177,927	1,079 Added 3.32%	33,619 $4.53 Million
Q1 2023 May 11, 2023	SELL	$144.61 - $166.54 $45,985 - $52,959	-318 Reduced 0.97%	32,540 $5.19 Million
Q4 2022 Jan 25, 2023	BUY	$138.31 - $165.87 $16,597 - $19,904	120 Added 0.37%	32,858 $0
Q3 2022 Oct 20, 2022	BUY	$134.21 - $153.93 $13,421 - $15,393	100 Added 0.31%	32,738 $4.39 Million
Q2 2022 Jul 19, 2022	SELL	$137.62 - $174.96 $10,321 - $13,122	-75 Reduced 0.23%	32,638 $5 Million
Q1 2022 Apr 08, 2022	BUY	$131.98 - $163.75 $91,198 - $113,151	691 Added 2.16%	32,713 $5.3 Million
Q4 2021 Feb 01, 2022	BUY	$107.43 - $135.93 $115,487 - $146,124	1,075 Added 3.47%	32,022 $4.34 Million
Q3 2021 Nov 05, 2021	BUY	$106.4 - $120.78 $70,543 - $80,077	663 Added 2.19%	30,947 $3.34 Million
Q2 2021 Aug 11, 2021	SELL	$105.21 - $117.21 $58,286 - $64,934	-554 Reduced 1.8%	30,284 $3.54 Million
Q1 2021 May 14, 2021	SELL	$102.3 - $112.62 $38,669 - $42,570	-378 Reduced 1.21%	30,838 $3.34 Million
Q4 2020 Feb 09, 2021	BUY	$80.49 - $108.67 $133,693 - $180,500	1,661 Added 5.62%	31,216 $3.35 Million
Q3 2020 Nov 10, 2020	BUY	$85.91 - $100.83 $41,838 - $49,104	487 Added 1.68%	29,555 $2.59 Million
Q2 2020 Jul 17, 2020	BUY	$73.37 - $98.18 $42,701 - $57,140	582 Added 2.04%	29,068 $2.85 Million
Q1 2020 Apr 29, 2020	SELL	$64.5 - $97.79 $116,358 - $176,413	-1,804 Reduced 5.96%	28,486 $2.17 Million
Q4 2019 Feb 04, 2020	SELL	$72.13 - $90.25 $53,159 - $66,514	-737 Reduced 2.38%	30,290 $2.52 Million
Q3 2019 Oct 22, 2019	BUY	$62.98 - $75.72 $70,411 - $84,654	1,118 Added 3.74%	31,027 $2.29 Million
Q2 2019 Jul 22, 2019	SELL	$65.7 - $83.98 $239,410 - $306,023	-3,644 Reduced 10.86%	29,909 $2.04 Million
Q1 2019 Apr 12, 2019	SELL	$77.14 - $90.79 $157,365 - $185,211	-2,040 Reduced 5.73%	33,553 $2.7 Million
Q4 2018 Jan 28, 2019	SELL	$77.85 - $96.01 $61,968 - $76,423	-796 Reduced 2.19%	35,593 $3.28 Million
Q3 2018 Nov 02, 2018	BUY	$88.91 - $98.84 $471,756 - $524,445	5,306 Added 17.07%	36,389 $2.83 Million
Q2 2018 Aug 10, 2018	BUY	$89.78 - $106.23 $45,428 - $53,752	506 Added 1.65%	31,083 $2.88 Million
Q1 2018 May 11, 2018	BUY	$92.01 - $123.21 $170,586 - $228,431	1,854 Added 6.45%	30,577 $2.89 Million
Q4 2017 Feb 09, 2018	BUY	$89.56 - $98.21 $2.57 Million - $2.82 Million	28,723	28,723 $2.78 Million

Others Institutions Holding ABBV

# of Institutions

4,095

Shares Held

1.28B

Call Options Held

16.7M

Put Options Held

15M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $357B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nikulski Financial, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Nikulski Financial, Inc. with notifications on news.

Account

Nikulski Financial, Inc. Abb Vie Inc. Transaction History